Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study

J Geriatr Oncol. 2023 Jun;14(5):101526. doi: 10.1016/j.jgo.2023.101526. Epub 2023 May 22.

Authors

Fabio P Mansani¹, Ruffo Freitas-Junior²

Affiliations

¹ Universidade Estadual de Ponta Grossa, Parana, Brazil. Electronic address: [email protected].
² Universidade Federal de Goias, Goiania, Brazil. Electronic address: [email protected].

PMID: 37225532
DOI: 10.1016/j.jgo.2023.101526

No abstract available

Keywords: Breast cancer; Endocrine therapy; Genomic risk profile; Geriatric oncology; Individualized treatment.

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms* / genetics
Cohort Studies
Female
Gene Expression Profiling
Humans
Neoplasm Recurrence, Local / genetics
Prognosis
Risk Factors